Compliance Rate

Compliance Rate 31.0%
Compliant submissions 31
Incompliant submissions 69
Total trials 100

Your Clinical Trials

Showing 75 of 100 entries
View as:

A Study of Itraconazole in Preventing the Return of Histoplasmosis, a Fungal Infection, in Patients With AIDS

Phase: N/A Priority: Normal
NCT ID: NCT00000992 Org: User:
Start: - End: 06/30/92 Due: 06/30/93

Risperidone for the Treatment of Cocaine Dependence - 7

Phase: N/A Priority: Normal
NCT ID: NCT00000342 Org: User:
Start: 07/31/96 End: 09/30/97 Due: 09/30/98

A Phase I/II Study of Delayed-Type Hypersensitivity (DTH) Reactions to Intradermal HIV Envelope Antigen

Phase: N/A Priority: Normal
NCT ID: NCT00000782 Org: User:
Start: - End: 10/31/96 Due: 10/31/97

Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00000882 Org: User:
Start: - End: - Due: -

Phase I Rising Dose Tolerability Study of SC-48334 in Patients With Acquired Immunodeficiency Syndrome (AIDS) and Advanced AIDS Related Complex

Phase: N/A Priority: Normal
NCT ID: NCT00000692 Org: User:
Start: - End: - Due: -

Glycine and D-Cycloserine in Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00000372 Org: User:
Start: 03/31/98 End: 11/30/05 Due: 11/30/06

Stroke Prevention in Sickle Cell Anemia (STOP 1)

Phase: N/A Priority: Normal
NCT ID: NCT00000592 Org: User:
Start: 07/31/94 End: 08/31/00 Due: 08/31/01

Aerosols in the Treatment of Pneumocystis Pneumonia: A Pilot Study Quantitating the Deposition of Aerosolized Pentamidine as Delivered in ACTG 040 and Comparing Its Toxicity With Parenteral Pentamidine Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00000722 Org: User:
Start: - End: 06/30/91 Due: 06/30/92

Cooperative Study of Factor VIII Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT00000582 Org: User:
Start: 07/31/78 End: 07/31/79 Due: 07/31/80

Carbamazepine Treatment of Cocaine Dependence - 1

Phase: N/A Priority: Normal
NCT ID: NCT00000242 Org: User:
Start: 10/01/92 End: 01/25/97 Due: 01/25/98

A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00000902 Org: User:
Start: - End: 04/30/02 Due: 04/30/03

Alternate Day Buprenorphine Administration, Phase IX - 14

Phase: N/A Priority: Normal
NCT ID: NCT00000232 Org: User:
Start: 03/31/92 End: - Due: -

Bypass Angioplasty Revascularization Investigation (BARI)

Phase: N/A Priority: Normal
NCT ID: NCT00000462 Org: User:
Start: 04/30/87 End: 11/30/04 Due: 11/30/05

A Randomized, Unblinded Trial of Zidovudine Versus ddC in the Treatment of Patients Status Post PCP Who Received Long-Term Zidovudine Therapy in Protocol ACTG 002

Phase: N/A Priority: Normal
NCT ID: NCT00000682 Org: User:
Start: - End: 09/30/92 Due: 09/30/93

High Dose Nimodipine Treatment Adjunct - 1

Phase: N/A Priority: Normal
NCT ID: NCT00000332 Org: User:
Start: 05/31/98 End: 04/30/00 Due: 04/30/01

A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive Individuals

Phase: N/A Priority: Normal
NCT ID: NCT00000772 Org: User:
Start: - End: 02/28/95 Due: 02/28/96

A Randomized, Placebo-Controlled, Double-Blinded Phase I Safety and Immunogenicity Trial of Recombinant Envelope Protein, HIV-1 SF-2 rgp120 (BIOCINE), Combined With MF59 in HIV-1 Uninfected Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00000832 Org: User:
Start: - End: 01/31/98 Due: 01/31/99

The Safety and Effectiveness of BI-RG-587 in HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00000962 Org: User:
Start: - End: - Due: -

A Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Envelope Proteins of HIV-1 gp160 and gp120 in Children >= 1 Month Old With Asymptomatic HIV Infection

Phase: N/A Priority: Normal
NCT ID: NCT00000762 Org: User:
Start: - End: 02/29/96 Due: 02/28/97

Women's Healthy Lifestyle Project: Cardiovascular Risk Factors and Menopause

Phase: N/A Priority: Normal
NCT ID: NCT00000532 Org: User:
Start: 02/29/92 End: 01/31/00 Due: 01/31/01

A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir

Phase: N/A Priority: Normal
NCT ID: NCT00000892 Org: User:
Start: - End: 08/31/99 Due: 08/31/00

Lyme Disease Prevention Program

Phase: N/A Priority: Normal
NCT ID: NCT00000432 Org: User:
Start: 04/30/97 End: 03/31/01 Due: 03/31/02

A Study of Zidovudine During Labor and Delivery in HIV-Infected Pregnant Women

Phase: N/A Priority: Normal
NCT ID: NCT00000862 Org: User:
Start: - End: 11/30/03 Due: 11/30/04

A Phase I Clinical Trial to Evaluate: Part A. The Safety of MTP-PE/MF59 Adjuvant Emulsion. Part B. The Safety and Immunogenicity of Env 2-3, a Yeast Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59

Phase: N/A Priority: Normal
NCT ID: NCT00000972 Org: User:
Start: - End: 04/30/92 Due: 04/30/93

A Phase II, Double-Blind Trial of Recombinant Human Nerve Growth Factor for Treatment of HIV-Associated Sensory Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT00000842 Org: User:
Start: - End: 02/28/99 Due: 02/28/00